Related Experiment Video
Updated: Aug 12, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
A case report of multiple abscesses caused by Streptococcus intermedius
Jonathan Vincent M Reyes1, Manasa Dondapati2, Saad Ahmad1
1Department of Internal Medicine Icahn School of Medicine at Mount Sinai Hospital (Elmhurst Hospital Center) New York New York USA.
Streptococcus intermedius, a bacterium, can cause severe abscesses in multiple organs. Prompt treatment involving drainage, surgery, and antibiotics is crucial for recovery.
Area of Science:
- Microbiology
- Infectious Diseases
Background:
- Streptococcus intermedius is a gram-positive bacterium belonging to the Streptococcus anginosus group.
- This bacterium is known to cause significant infections compared to other group members.
Observation:
- A case study of a 47-year-old male patient with Streptococcus intermedius infections is presented.
- The patient presented with abscesses in the lungs, liver, and brain.
Findings:
- Streptococcus intermedius was identified as the causative agent of multiple organ abscesses.
- The infections were substantial, affecting critical organs.
Implications:
- Early diagnosis and intervention are vital for managing Streptococcus intermedius infections.
- Optimal treatment involves a multi-modal approach including drainage, surgical intervention, and antibiotic therapy.
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Acute Pyelonephritis II: Diagnostic Studies and Management
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Urinary Tract Infection II: Pathophysiology
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

